TP53 (33.8%), ATM (30.0%), CCND1 (20.3%), KMT2D (14.9%), and NSD2 (13.5%) were the most recurrently mutated genes in the MCL cohort (Figure 2D). This evidence concerns the gene CCND1 and mantle cell lymphoma.